Gene · 55937
APOM: apolipoprotein M
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. APOM: apolipoprotein M. Genes, record 55937. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/55937
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O95445 | Apolipoprotein M | 188 | 3 | Ensembl, GeneID, HGNC |
Source UniProt
Patents170
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4650780 A2 | 2025-11-19 | 9711 | O95445 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 1012 | O95445 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 2489 | O95445 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 2600 | O95445 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 2897 | O95445 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 2930 | O95445 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 2940 | O95445 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 2974 | O95445 | Espacenet |
| JP 2025138725 A | 2025-09-25 | 3006 | O95445 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 5514 | O95445 | Espacenet |
1 to 10 of 170
See all 170 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants849
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | APOM papers | Newest fiscal year |
|---|---|---|---|
| P30DK017047 | Diabetes Research Center | 8 | 2025 |
| P01HL116263 | HDL Function in Human Disease | 5 | 2025 |
| P30DK035816 | Nutrition Obesity Research Center | 4 | 2025 |
| P30DK056341 | Washington University Nutrition Obesity Research Center | 4 | 2025 |
| ZIADK056014 | Mouse Models of Novel Sphingolipid Biology and Disease Mechanisms | 4 | 2025 |
| P01HL128203 | Multi-disciplinary Approaches to HDL Structure, Assembly, and Functional Heterogeneity | 3 | 2025 |
| P30CA016059 | Massey Cancer Center - Cancer Center Support Grant | 3 | 2025 |
| P30DK020579 | Diabetes Research Center | 3 | 2025 |
| R01EY031715 | G protein-coupled receptor regulation of transcriptional mechanisms in the retinal vasculature. | 3 | 2025 |
| R01HL155344 | Apolipoprotein M: a novel regulator of myocardial Autophagy | 3 | 2025 |
1 to 10 of 849Source NIH's project files
See all 849 nih grantsPapers1,335
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mapping the Immune cell-specific gene regulatory network in bipolar disorder: A framework from scTWMR to exploratory drug-target annotation. | Psychiatry Res | 2026 | 42743600 | PubTator, text mining | PubMed |
| Unraveling causal links between chronic rhinosinusitis and peripheral artery diseases: insights from genetic correlations through genome-wide association studies. | Braz J Otorhinolaryngol | 2026 | 42685396 | PubTator, text mining | PubMed |
Mapping the immune-genetic architecture of Epstein-Barr virus-related phenotypes and multiple sclerosis through a single-cell genetic framework for target prioritization and pharmacologic hypothesis generation. | Mult Scler Relat Disord | 2026 | 42570508 | PubTator, text mining | PubMed |
| The Effect of Iatrogenic Hypothyroidism on Lipoprotein Subfractions and Markers of HDL Function in Patients with Differentiated Thyroid Carcinoma. | Life (Basel) | 2026 | 42514153 | PubTator, text mining | PubMed |
| Exploring Targets for Heart Failure Using Mendelian Randomization, Colocalization, Summary Data-based Mendelian Randomization, and Drug Prediction. | J Vis Exp | 2026 | 42507612 | PubTator, text mining | PubMed |
| Cardiovascular-Kidney-Metabolic Syndrome Staging and Cancer Risk: Insights From Proteomic and Metabolomic Mediators. | JACC CardioOncol | 2026 | 42455107 | PubTator, text mining | PubMed |
| APOM-S1P axis as a therapeutic target in steroid sensitive nephrotic syndrome. | Pediatr Nephrol | 2026 | 42400614 | PubTator, text mining | PubMed |
| Longitudinal Cognitive Evolution in Alcohol Use Disorder Patients: Role of Inflammation, Time of Abstinence and Apolipoprotein Profile. | Addict Biol | 2026 | 42386626 | PubTator, text mining | PubMed |
| Alterations of sphingosine-1-phosphate and its receptors in type 1 diabetes mellitus: an integrated clinical and single-cell transcriptomic study. | Front Immunol | 2026 | 42338584 | PubTator, text mining | PubMed |
| Unravelling the conformational dynamics of pathogenic mutations of apolipoprotein M: an integrative computational and molecular dynamics simulation approach. | J Biomol Struct Dyn | 2026 | 42301260 | PubTator, text mining | PubMed |
1 to 10 of 1,335
See all 1,335 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/55937
GET https://conductscience.org/api/genes/v1/55937/patents?page=2